Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5445
pubmed:dateCreated
1999-12-14
pubmed:abstractText
Extracellular signals often result in simultaneous activation of both the Raf-MEK-ERK and PI3K-Akt pathways (where ERK is extracellular-regulated kinase, MEK is mitogen-activated protein kinase or ERK kinase, and PI3K is phosphatidylinositol 3-kinase). However, these two signaling pathways were shown to exert opposing effects on muscle cell hypertrophy. Furthermore, the PI3K-Akt pathway was shown to inhibit the Raf-MEK-ERK pathway; this cross-regulation depended on the differentiation state of the cell: Akt activation inhibited the Raf-MEK-ERK pathway in differentiated myotubes, but not in their myoblast precursors. The stage-specific inhibitory action of Akt correlated with its stage-specific ability to form a complex with Raf, suggesting the existence of differentially expressed mediators of an inhibitory Akt-Raf complex.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cdkn1a protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclins, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Flavonoids, http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Myog protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Myogenin, http://linkedlifedata.com/resource/pubmed/chemical/PD 98059, http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 3-Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-akt, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-raf
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0036-8075
pubmed:author
pubmed:issnType
Print
pubmed:day
26
pubmed:volume
286
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1738-41
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:10576741-Animals, pubmed-meshheading:10576741-Cell Differentiation, pubmed-meshheading:10576741-Cell Line, pubmed-meshheading:10576741-Cyclin-Dependent Kinase Inhibitor p21, pubmed-meshheading:10576741-Cyclins, pubmed-meshheading:10576741-Enzyme Activation, pubmed-meshheading:10576741-Enzyme Inhibitors, pubmed-meshheading:10576741-Flavonoids, pubmed-meshheading:10576741-Insulin-Like Growth Factor I, pubmed-meshheading:10576741-MAP Kinase Signaling System, pubmed-meshheading:10576741-Mice, pubmed-meshheading:10576741-Mitogen-Activated Protein Kinases, pubmed-meshheading:10576741-Muscle, Skeletal, pubmed-meshheading:10576741-Myogenin, pubmed-meshheading:10576741-Phenotype, pubmed-meshheading:10576741-Phosphatidylinositol 3-Kinases, pubmed-meshheading:10576741-Phosphorylation, pubmed-meshheading:10576741-Protein-Serine-Threonine Kinases, pubmed-meshheading:10576741-Proto-Oncogene Proteins, pubmed-meshheading:10576741-Proto-Oncogene Proteins c-akt, pubmed-meshheading:10576741-Proto-Oncogene Proteins c-raf, pubmed-meshheading:10576741-Signal Transduction, pubmed-meshheading:10576741-Transfection, pubmed-meshheading:10576741-Transgenes
pubmed:year
1999
pubmed:articleTitle
Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt.
pubmed:affiliation
Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.
pubmed:publicationType
Journal Article